On October 9, 2026 Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, reported that members of senior management will participate in the Maxim Growth Summit 2026 on Wednesday, October 14, 2026 in New York.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:

Panel Discussion: Immunology & Inflammation Therapies
Presenter: Ron Bentsur, Chairman and CEO
Date and Time: Wednesday, October 14, 2026 at 10:30 AM ET
Webcast link: Panel Discussion
A webcast of the panel discussion will be available in the Investors section of Nuvectis’ website at www.nuvectis.com.

(Press release, Nuvectis Pharma, OCT 9, 2026, View Source [SID1234673314])